Answers are grounded in this paper and cite their sources.
Peptides are composed of short-to medium-chain amino acid molecules that combine the bioactivity of proteins with the structural tunability of small molecules, enabling broad applications in antimicrobial, anticancer, and functional materials. Compared with small molecule drugs, they often offer higher specificity, better biocompatibility, and lower immunogenicity, yet their vast combinatorial space (about 8000 possible tripeptides and over 3 million pentapeptides) and ultimately astronomical diversity with the increment of peptide sequence. The relationship between complex structure and function makes purely experimental screening inefficient. In this review article, we summarize the recent advances in machine learning that enable the mapping of sequence, structure, and function from existing data, supporting accurate property prediction and rational design. Coupled with expanding databases and simulations, these approaches have driven progress across multiple domains. Machine learning transcends empirical limitations in peptide science, enabling the discovery of potent antimicrobial, anticancer, and self-assembling peptides and guiding their design through a loop from data to prediction and validation, which accelerates drug and material development.
No takes yet. Share an insight, caveat, or question.
Wan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: